Zobrazeno 1 - 10
of 1 504
pro vyhledávání: ''
Autor:
Gian Carlo Mattiucci, Lisa Salvatore, Andrea D’Aviero, Cinzia Bagalà, Maria Bensi, Francesco Mosè Castronovo, Francesco Cellini, Paola De Franco, Brunella Di Stefano, Gabriella Macchia, Valeria Masiello, Roberta Menghi, Giuseppe Quero, Sara Reina, Alessio Giuseppe Morganti, Sergio Alfieri, Giampaolo Tortora, Vincenzo Valentini
Publikováno v:
Oncology Research and Treatment. 45:588-597
Introduction: Pancreatic cancer (PC) represents an unfavorable prognosis condition, even in patients with resectable disease. The aim of this series was to investigate the role of treatment intensification with adjuvant chemoradiation (CRT) in radica
Publikováno v:
Oncol Res Treat
Background: The objective of this study was to investigate the clinical characteristics, diagnosis, and treatment of inflammatory myofibroblastoma tumor (IMT) in the thyroid gland. Methods: A total of 17 patients with IMT by pathology from 2010 to 20
Autor:
Kazuaki Okamoto, Hiroaki Nozawa, Shigenobu Emoto, Koji Murono, Kazuhito Sasaki, Soichiro Ishihara
Publikováno v:
Oncology. 100:576-582
Introduction: Adjuvant chemotherapy improves the prognosis of patients with colorectal cancer (CRC) following radical resection. However, the safety and efficacy of oxaliplatin-based chemotherapeutic regimens for elderly patients remains to be elucid
Autor:
Hidetoshi Yasuoka, Atsushi Naganuma, Eishin Kurihara, Tsutomu Kobatake, Masashi Ijima, Yuki Tamura, Yuhei Suzuki, Takashi Hoshino, Fumiya Ishida, Hisashi Hosaka, Takeshi Hatanaka, Sachiko Yoshida, Ryusuke Aihara, Yasuo Hosouchi, Norihiro Ishii, Kenichiro Araki, Ken Shirabe, Toshio Uraoka, Satoru Kakizaki
Publikováno v:
Oncology. 100:449-459
Introduction: This retrospective study investigated the efficacy and safety of nano-liposomal irinotecan (nal-IRI) plus 5-fluorouracil/L-leucovorin (5-FU/l-LV) treatment in the second-line or later setting for advanced pancreatic cancer under real-wo
Autor:
Mohammed B. Allaw, Jeffrey M. Switchenko, Lana Khalil, Christina Wu, Olatunji B. Alese, Mehmet Akce, Amber Draper, Aaron T. Jones, Bassel El-Rayes, Walid Shaib
Publikováno v:
Oncology
Background: The 2 approved somatostatin analogs (SSAs) in the first-line treatment of advanced, well-differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are octreotide long-acting release (Sandostatin LAR) and somatuline depot (Lan
Autor:
Moying Li, Nadine Schulte, Frederik Elting, Eva C. Winkler, Svetlana Hetjens, Anne Katrin Berger, Stefanie Zschäbitz, Jan Hofmann, Jasmin Hofmann, Lieselotte Hilbertz, Merlin Kuhn, Carolin Khakzar, Ralf Jesenofsky, Johannes Betge, Tianzuo Zhan, Sebastian Belle, Matthias Philip Ebert, Nicolai Härtel
Publikováno v:
Oncology Research and Treatment. 45:670-680
Introduction: Colorectal cancer (CRC) is a disease of older patients, but evidence-based guidelines for chemotherapy in older patients are scarce. Geriatric assessment (GA) evaluates a patient’s functional status (FS) and helps in decision-making w
Autor:
Karin Berger, Reinhard Henschler, Vanessa Kratzer, Christina Rieger, Georg Wittmann, Helmut Ostermann
Publikováno v:
Oncology Research and Treatment. 45:336-343
Introduction: In Germany, up to 75% of platelet concentrates (PCs) are administered to haematological and oncological patients. Only limited transparency exists on the characteristics of haematological/oncological patients receiving PC transfusions,
Autor:
Takahito Negishi, Akira Matsunobu, Makoto Endo, Ryouhei Yokoyama, Shuhei Kusano, Nobuki Furubayashi, Kenichi Taguchi, Yoshiyuki Shioyama, Keiichiro Iida, Toshifumi Fujiwara, Nokitaka Setsu, Yoshihiro Matsumoto, Yasuharu Nakashima, Kenichi Kohashi, Hidetaka Yamamoto, Yoshinao Oda, Motonobu Nakamura
Publikováno v:
Oncology. 100:148-154
Introduction: Radiation-associated sarcoma (RAS) is one of the most life-threatening complications associated with the treatment of malignant neoplasms. Because all RAS patients have a history of radiotherapy, there have been no effective treatment o
Publikováno v:
Oncology. 100:155-162
Introduction: Not only the 21-gene recurrence score (RS) assay but also online prognostic tools and immunohistochemical prognostic models predict chemotherapy benefits for women with early breast cancer (BC). Multigene assays, including Oncotype DX,
Autor:
Tadashi Shiraishi, Takeshi Toyozumi, Haruhito Sakata, Kentaro Murakami, Masayuki Kano, Yasunori Matsumoto, Masaya Yokoyama, Koichiro Okada, Toshiki Kamata, Takahiro Ryuzaki, Kazuya Kinoshita, Soichiro Hirasawa, Hisahiro Matsubara
Publikováno v:
Oncology. 100:39-47
Introduction: We determined the soluble programmed cell death-1 ligand-1 (sPD-L1) concentration in patients with esophageal squamous cell carcinoma (ESCC), and confirmed the PD-L1 expression in resected specimens. Methods: Blood samples were collecte